Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Orbis Medicines ApS
APS
Active
Reklamebeskyttelse
CVR 42715646
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
27 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Orbis Medicines ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-4M
-9M
-13M
-17M
-15M
2022
-26M
2023
-52M
2024
EBITDA
DKK millions
0M
-16M
-33M
-49M
-65M
-15M
2022
-26M
-73%
2023
-52M
-100%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
-15.220
-25.596
-51.629
Staff expenses
-140
-0
-493
EBITDA
-15.360
-25.596
-52.122
Depreciation & amort.
-0
-0
-0
EBIT
-15.360
-25.596
-52.122
Net financials
899
2.093
3.597
Profit before tax
-14.461
-23.503
-48.526
Tax
-3.411
-5.865
-11.505
Net profit
-11.049
-17.638
-37.021
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
28.713
70.366
158.639
Equity
26.987
68.950
127.020
Long-term debt
0
0
0
Short-term debt
1.726
1.416
31.620
Total debt
1.726
1.416
31.620
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-5212218800.0%
This company
2022
2024
Soliditetsgrad
80.1%
This company
38.2%
Market median
+110% vs market
2022
2024
Egenkapitalforrentning
-29.1%
This company
18.4%
Market median
-258% vs market
2022
2024
Nettoresultatgrad (af bruttofortjeneste)
-3702093300.0%
This company
2022
2024
Aktivomsætning (af bruttofortjeneste)
-0.33×
This company
2022
2024
Gæld/egenkapital
0.25×
This company
0.62×
Market median
+60% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-09-28 – 2022-12-31
View
PDF
More on Orbis Medicines ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
